CLINICAL_TRIALS
trial_result
· 2012-03-08
Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration [Phase 2]
Summary
Phase 2 trial update evaluating safety, PK, and PD of subcutaneous CINRYZE in hereditary angioedema has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 2 | Status: COMPLETED | Results posted: 2012-03-08